BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30023184)

  • 1. Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features.
    Alshenawy HA
    J Microsc Ultrastruct; 2015; 3(2):68-74. PubMed ID: 30023184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
    Alshenawy HA
    Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma with clear cell and papillary features.
    Ross H; Martignoni G; Argani P
    Arch Pathol Lab Med; 2012 Apr; 136(4):391-9. PubMed ID: 22458901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
    Pramick M; Ziober A; Bing Z
    Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
    Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
    Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances of immunohistochemistry for diagnosis of renal tumors.
    Kuroda N; Tanaka A; Ohe C; Nagashima Y
    Pathol Int; 2013 Aug; 63(8):381-90. PubMed ID: 23957913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
    He H; Zhou GX; Zhou M; Chen L
    Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
    Olgac S; Hutchinson B; Tickoo SK; Reuter VE
    Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomorphology of clear cell papillary renal cell carcinoma.
    Lin X
    Cancer Cytopathol; 2017 Jan; 125(1):48-54. PubMed ID: 27636377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
    Griffin BB; Lin X
    Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
    Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
    Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
    Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
    Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes.
    Kim M; Joo JW; Lee SJ; Cho YA; Park CK; Cho NH
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.
    Paner GP; Srigley JR; Radhakrishnan A; Cohen C; Skinnider BF; Tickoo SK; Young AN; Amin MB
    Am J Surg Pathol; 2006 Jan; 30(1):13-9. PubMed ID: 16330937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile.
    Williamson SR; Eble JN; Cheng L; Grignon DJ
    Mod Pathol; 2013 May; 26(5):697-708. PubMed ID: 23238627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
    Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
    Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.